• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

What happened in optometry this week: February 5-February 9

Blog
Article

Catch up on what happened in optometry during the week of February 5-February 9.

Catch up with what Optometry Times shared this week:

FDA accepts IND for OK-101 for neuropathic corneal pain

By Emily Kaiser Maharjan, Assistant Managing Editor

OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

Read here...

UC optometrists strike over “bad-faith” bargaining practices, protest low salaries

By Jordana Joy, Associate Editor

Members of the University Professional and Technical Employees CWA Local 9119 drew picket lines on February 6 and 7 to protest unfair labor and bargaining practices upheld by University of California.

Read here...

Gaps in vision screening for school-aged children uncovered in study

By Lynda Charters

A new study found that only a little over half of school-aged children participants underwent vision screening within the past two years, highlighting gaps in eye care access.

Read here...

Diagnosing and treating Demodex blepharitis

By Amy Nau, OD, Dipl CCLRT; Lynda Charters

Everything, no matter how minute, has a purpose and so that must also be the case for the pesky Demodex mite, the infective parasites that lie between or on the eyelashes in highly sebaceous areas. Some researchers think these parasites may help control bacterial populations through their acidic secretions. However, their waste can cause inflammation and hypersensitivity reactions in affected individuals.

Read here...

ALSTAR study identifies potential functional biomarker for early, intermediate AMD

By Lynda Charters

The study further defined the relationship between delayed rod-mediated dark adaptation and the status of outer retinal bands on optical coherence tomography.

Read here...

Related Videos
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Andrew Pucker, OD, PhD
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
© 2024 MJH Life Sciences

All rights reserved.